Roflumilast ameliorates cognitive impairment in APP/PS1 mice via cAMP/CREB/BDNF signaling and anti-neuroinflammatory effects

Title
Roflumilast ameliorates cognitive impairment in APP/PS1 mice via cAMP/CREB/BDNF signaling and anti-neuroinflammatory effects
Authors
Keywords
Roflumilast, Phosphodiesterase-4, Alzheimer’s disease, cAMP-response element binding protein (CREB), Neuroinflammation, Cognition
Journal
METABOLIC BRAIN DISEASE
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-01-05
DOI
10.1007/s11011-018-0374-4

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started